BEAM
Price
$23.73
Change
-$0.68 (-2.79%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
2.4B
47 days until earnings call
EYPT
Price
$13.39
Change
+$0.03 (+0.22%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
922.94M
35 days until earnings call
Interact to see
Advertisement

BEAM vs EYPT

Header iconBEAM vs EYPT Comparison
Open Charts BEAM vs EYPTBanner chart's image
Beam Therapeutics
Price$23.73
Change-$0.68 (-2.79%)
Volume$29.71K
Capitalization2.4B
EyePoint Pharmaceuticals
Price$13.39
Change+$0.03 (+0.22%)
Volume$8.09K
Capitalization922.94M
BEAM vs EYPT Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. EYPT commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and EYPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (BEAM: $23.73 vs. EYPT: $13.39)
Brand notoriety: BEAM and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 68% vs. EYPT: 63%
Market capitalization -- BEAM: $2.4B vs. EYPT: $922.94M
BEAM [@Biotechnology] is valued at $2.4B. EYPT’s [@Biotechnology] market capitalization is $922.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while EYPT’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • EYPT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than EYPT.

Price Growth

BEAM (@Biotechnology) experienced а +3.58% price change this week, while EYPT (@Biotechnology) price change was -1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +44.37%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

EYPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.4B) has a higher market cap than EYPT($923M). EYPT YTD gains are higher at: 79.732 vs. BEAM (-4.315). EYPT has higher annual earnings (EBITDA): -172.05M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. EYPT (256M). EYPT has less debt than BEAM: EYPT (21.8M) vs BEAM (155M). BEAM has higher revenues than EYPT: BEAM (60.3M) vs EYPT (51.9M).
BEAMEYPTBEAM / EYPT
Capitalization2.4B923M260%
EBITDA-414.33M-172.05M241%
Gain YTD-4.31579.732-5%
P/E RatioN/AN/A-
Revenue60.3M51.9M116%
Total Cash1.15B256M449%
Total Debt155M21.8M711%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMEYPT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 22 days ago
85%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYECX194.94N/A
N/A
Rydex Energy C
ADGAX26.55N/A
N/A
AB Core Opportunities A
CFJIX35.81N/A
N/A
Calvert US Large Cap Value Rspnb Idx I
VGYAX28.68N/A
N/A
Vanguard Global Wellesley Income Admiral
MKVCX16.79N/A
N/A
MFS International Large Cap Value C

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.22%
OCUL - EYPT
64%
Loosely correlated
+0.41%
LYRA - EYPT
58%
Loosely correlated
+3.43%
ATHE - EYPT
54%
Loosely correlated
+0.72%
BEAM - EYPT
53%
Loosely correlated
-2.79%
RXRX - EYPT
51%
Loosely correlated
-3.41%
More